Metabolic Effects of Bariatric Surgery

被引:25
作者
Sinclair, Piriyah [1 ]
Docherty, Neil [1 ,2 ]
le Roux, Carel W. [1 ,2 ,3 ]
机构
[1] Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Dublin, Ireland
[2] Univ Gothenburg, Sahlgrenska Acad, Gastrosurg Lab, Gothenburg, Sweden
[3] Imperial Coll London, Investigat Med, London, England
关键词
GASTRIC BYPASS-SURGERY; POLYCYSTIC-OVARY-SYNDROME; TYPE-2; DIABETES-MELLITUS; GLUCAGON-LIKE PEPTIDE-1; RANDOMIZED-CONTROLLED-TRIAL; NATIONAL LIPID ASSOCIATION; SWEDISH OBESE SUBJECTS; HUMAN GUT MICROBIOTA; FATTY LIVER-DISEASE; INSULIN-RESISTANCE;
D O I
10.1373/clinchem.2017.272336
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Obesity can be defined as a chronic subcortical brain disease, as there is an important neurophysiological component to its etiology based on changes in the functioning of those areas of the brain controlling food intake and reward. Extensive metabolic changes accompany bariatric surgery-based treatment of obesity. Consequently, the term "metabolic" surgery is being increasingly adopted in relation to the beneficial effects these procedures have on chronic diseases like type 2 diabetes. CONTENT: In the present review, we focus on the key biochemical and physiological changes induced by metabolic surgery and highlight the beneficial effects accrued systemically with the use of an organ-based approach. Understanding the impact on and interactions between the gut, brain, adipose tissue, liver, muscle, pancreas, and kidney is key to understanding the sum of the metabolic effects of these operations. SUMMARY: Further mechanistic studies are essential to assess the true potential of metabolic surgery to treat metabolic comorbidities of obesity beyond type 2 diabetes. Approaches that may mitigate the metabolic side effects of surgery also require attention. Understanding the positive impact of metabolic surgery on metabolic health may result in a wider acceptance of this intervention as treatment for metabolic, comorbid conditions. (c) 2017 American Association for Clinical Chemistry
引用
收藏
页码:72 / 81
页数:10
相关论文
共 88 条
[1]   Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].
Adler, AI ;
Stevens, RJ ;
Manley, SE ;
Bilous, RW ;
Cull, CA ;
Holman, RR .
KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232
[2]   MECHANISMS IN ENDOCRINOLOGY Gut microbiota in patients with type 2 diabetes mellitus [J].
Allin, Kristine H. ;
Nielsen, Trine ;
Pedersen, Oluf .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (04) :R167-R177
[3]   Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study [J].
Anveden, Asa ;
Taube, Magdalena ;
Peltonen, Markku ;
Jacobson, Peter ;
Andersson-Assarsson, Johanna C. ;
Sjoholm, Kajsa ;
Svensson, Per-Arne ;
Carlsson, Lena M. S. .
GYNECOLOGIC ONCOLOGY, 2017, 145 (02) :224-229
[4]   Bariatric surgery and endometrial pathology in asymptomatic morbidly obese women: a prospective, pilot study [J].
Argenta, P. A. ;
Kassing, M. ;
Truskinovsky, A. M. ;
Svendsen, C. A. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 (07) :795-800
[5]   Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery [J].
Argenta, Peter ;
Svendsen, Charles ;
Elishaev, Esther ;
Gloyeske, Nika ;
Geller, Melissa A. ;
Edwards, Robert P. ;
Linkov, Faina .
GYNECOLOGIC ONCOLOGY, 2014, 133 (01) :78-82
[6]   Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study [J].
Armstrong, Matthew James ;
Gaunt, Piers ;
Aithal, Guruprasad P. ;
Barton, Darren ;
Hull, Diana ;
Parker, Richard ;
Hazlehurst, Jonathan M. ;
Guo, Kathy ;
Abouda, George ;
Aldersley, Mark A. ;
Stocken, Deborah ;
Gough, Stephen C. ;
Tomlinson, Jeremy W. ;
Brown, Rachel M. ;
Huebscher, Stefan G. ;
Newsome, Philip N. .
LANCET, 2016, 387 (10019) :679-690
[7]   Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women [J].
Asztalos, Bela F. ;
Swarbrick, Michael M. ;
Schaefer, Ernst J. ;
Dallal, Gerard E. ;
Horvath, Katalin V. ;
Ai, Masumi ;
Stanhope, Kimber L. ;
Austrheim-Smith, Iselin ;
Wolfe, Bruce M. ;
Ali, Mohamed ;
Havel, Peter J. .
JOURNAL OF LIPID RESEARCH, 2010, 51 (08) :2405-2412
[8]   Biology of incretins: GLP-1 and GIP [J].
Baggio, Laurie L. ;
Drucker, Daniel J. .
GASTROENTEROLOGY, 2007, 132 (06) :2131-2157
[9]  
Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4
[10]   Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: EXECUTIVE SUMMARY [J].
Bays, Harold E. ;
Jones, Peter H. ;
Jacobson, Terry A. ;
Cohen, David E. ;
Orringer, Carl E. ;
Kothari, Shanu ;
Azagury, Dan E. ;
Morton, John ;
Nguyen, Ninh T. ;
Westman, Eric C. ;
Horn, Deborah B. ;
Scinta, Wendy ;
Primack, Craig .
JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (01) :15-32